Indian company: «Corona vaccine» will be available within two weeks «AstraZenka»
Today, Saturday, November 28, a giant Indian company announced that it will apply within two weeks for an emergency license to produce a vaccine against the emerging corona virus, Covid 19.
The CEO of the "Institute of Serology of India" said that the institute will be available from the beginning of 2021 to produce at least 100 million doses of the "Coffeeshield" vaccine, which was developed by the "AstraZenka" company in cooperation with the University of Oxford.
The statement by the CEO of the Institute of Serology of India came after a visit by the Indian Prime Minister, Narendra Modi, whose government wants 300 to 400 million doses by July of next year.
And the Indian company said that its experiments prove the success of its vaccine by 70%, and added that the percentage jumped to 90% when giving half an initial dose and then a full dose.
AstraZeneca did not state that the higher efficacy rate only applied to people 55 years of age or younger, but it insisted that these results would not affect regulatory approval.
It is noteworthy that India is the country most affected by the emerging corona epidemic, and India has recorded more than 9 million and 351 thousand and 110 cases of the emerging corona virus, Covid 19, after recording 41,322 new cases of the virus today, Saturday, November 28.
akhbarelyom
